Bortezomib and thalidomide treatment of newly diagnosed patients with multiple myeloma - Efficacy and neurotoxicity.

被引:13
|
作者
Borrello, Ivan [1 ]
Ferguson, Anna [1 ]
Huff, Carol Ann [1 ]
George, Shirley [1 ]
Biedryzcki, Barbara [1 ]
Cornblath, David [1 ]
Chaudhry, Vinay [1 ]
机构
[1] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
关键词
D O I
10.1182/blood.V108.11.3528.3528
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3528
引用
收藏
页码:1006A / 1006A
页数:1
相关论文
共 50 条
  • [21] SAFETY AND EFFICACY OF SUBCUTANEOUS VERSUS INTRAVENOUS BORTEZOMIB IN PATIENTS WITH NEWLY ELDERLY DIAGNOSED MULTIPLE MYELOMA
    Bacchiarri, F.
    Nozzoli, C.
    Antonioli, E.
    Staderini, M.
    Barone, F.
    Guarrera, A.
    Messeri, M.
    Coltro, G.
    Grieco, P.
    Bosi, A.
    HAEMATOLOGICA, 2017, 102 : 167 - 167
  • [22] Efficacy and safety of bortezomib maintenance in patients with newly diagnosed multiple myeloma: a meta-analysis
    Sun, Chun-yan
    Li, Jun-ying
    Chu, Zhang-bo
    Zhang, Lu
    Chen, Lei
    Hu, Yu
    BIOSCIENCE REPORTS, 2017, 37
  • [23] EFFICACY AND SAFETY OF THREE SUBCUTANEOUS BORTEZOMIB COMBINATIONS IN ELDERLY, NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Cerrato, C.
    Oliva, S.
    Petrucci, M. T.
    Caraffa, P.
    Nozzoli, C.
    Finsinger, P.
    Larocca, A.
    De Rosa, L.
    De Paoli, L.
    Montefusco, V.
    Saraci, E.
    Villani, O.
    Carella, A. M.
    Benevolo, G.
    Morabito, F.
    Liberati, A. M.
    Derudas, D.
    Boccadoro, M.
    Sonneveld, P.
    Palumbo, A.
    HAEMATOLOGICA, 2014, 99 : 107 - 107
  • [24] Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: A Chinese experience
    Zheng, Weiyan
    Wei, Guoqing
    Ye, Xiujin
    He, Jingsong
    Li, Li
    Wu, Wenjun
    Shi, Jimin
    Zhang, Jie
    Huang, Weijia
    Xie, Wanzhuo
    Luo, Yi
    Xue, Xingkui
    Lin, Maofang
    Huang, He
    Cai, Zhen
    LEUKEMIA RESEARCH, 2009, 33 (12) : 1615 - 1618
  • [25] The efficacy and tolerability of bortezomib, thalidomide, and dexamethasone induction therapy with a thalidomide dose step-up strategy in patients with newly diagnosed multiple myeloma: A prospective observational study
    Liao, Po-Wei
    Lu, Hsueh-Ju
    Chen, Tsung-Chih
    Lin, Hsin-Chen
    Shih, Yu-Hsuan
    Teng, Chieh-Lin Jerry
    CANCER REPORTS, 2024, 7 (05)
  • [26] The Choice Of Regimens Based On Bortezomib For Patients With Newly Diagnosed Multiple Myeloma
    Yang, Li
    He, Jingsong
    Han, Xiaoyan
    Zheng, Gaofeng
    Zheng, Weiyan
    Wei, Guoqing
    Wu, Wenjun
    Ye, Xiujin
    Shi, Jimin
    Xie, Wanzhuo
    Li, Li
    Zhang, Jie
    Huang, Weijia
    Zhao, Yi
    Huang, He
    Zhang, Xuejin
    Fu, Jiaping
    Cai, Zhen
    BLOOD, 2013, 122 (21)
  • [27] Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients
    Mersin, Sinan
    Geduk, Ayfer
    Mehtap, Ozgur
    Tarkun, Pinar
    Unal, Serkan
    Polat, Merve Gokcen
    Aygun, Kemal
    Yenihayat, Emel Merve
    Albayrak, Hayrunnisa
    Hacihanifioglu, Abdullah
    TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 (03) : 211 - 217
  • [28] Combination Therapy Based on Bortezomib for Newly Diagnosed Multiple Myeloma Patients
    He, Jingsong
    Yang, Li
    Jin, Dian
    Lin, Xuanru
    Yang, Qianqian
    Han, Xiaoyan
    Zheng, Gaofeng
    Zheng, Weiyan
    Wei, Guoqing
    Wu, Wenjun
    Ye, Xiujin
    Shi, Jimin
    Xie, Wanzhuo
    Zhang, Jie
    Lin, Maofang
    Huang, He
    Cai, Zhen
    BLOOD, 2012, 120 (21)
  • [29] COMBINATION THERAPY BASED ON BORTEZOMIB FOR PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Cai, C.
    He, J.
    Yang, Y.
    Han, H.
    Zheng, G.
    Zheng, W.
    Wei, W.
    Wu, W.
    Ye, Y.
    Shi, S.
    Xie, X.
    Li, L.
    Zhang, Z.
    Huang, H.
    Huang, H.
    Zhen, Z.
    HAEMATOLOGICA, 2012, 97 : 611 - 611
  • [30] The Choice of Regimens Based on Bortezomib for Patients with Newly Diagnosed Multiple Myeloma
    He, Jingsong
    Yang, Li
    Han, Xiaoyan
    Zheng, Gaofeng
    Zheng, Weiyan
    Wei, Guoqing
    Wu, Wenjun
    Ye, Xiujin
    Shi, Jimin
    Xie, Wanzhuo
    Li, Li
    Zhang, Jie
    Huang, Weijia
    Zhao, Yi
    Huang, He
    Zhang, Xuejin
    Fu, Jiaping
    Cai, Zhen
    PLOS ONE, 2014, 9 (06):